Human Albumin

About Shanghai RAAS Blood Products

Shanghai RAAS's mission is to ensure a stable, safe, and sufficient supply of plasma-derived therapeutics for the Chinese market, serving as a cornerstone of national biosecurity. The company has achieved a leading market position through strategic vertical integration, operating one of the largest networks of plasma collection stations and state-of-the-art fractionation facilities in the country. Its strategy is anchored in scaling plasma collection, expanding its high-value product portfolio (particularly immunoglobulins and factor concentrates), and maintaining technological leadership in viral safety and yield optimization. RAAS is poised for sustained growth driven by rising clinical demand, favorable reimbursement policies, and China's strategic push for plasma product self-sufficiency.

About Hualan Biological Engineering

Hualan Biological Engineering's mission is to safeguard public health through the research, development, and large-scale manufacturing of high-quality vaccines and plasma-based therapeutics. The company has achieved a leading market share in China's influenza vaccine segment and built a formidable, asset-heavy business model anchored by its extensive plasma station network and established manufacturing platforms. Its strategy focuses on defending its core franchises while strategically investing in next-generation vaccine technologies, including cell culture-based production and conjugate vaccines, to drive future growth and enhance pandemic preparedness.

Therapeutic Areas